 |
 |
 |
Search IPO GMP:
Goldline Pharmaceutical IPO GMP
Goldline Pharmaceutical IPO is an SME IPO, the company will raise up to 11 crore 61 lakh rupees for 27,00,000 shares. The IPO comprises a fresh issue of 27,00,000 shares (aggregating up to 11 crore 61 lakh rupees), and an offer for sale (OFS) of NIL.
| Goldline Pharmaceutical IPO GMP (Grey Market Premium) | |
| Premium From IPO Cut-off Price | |
| IPO Price Band | ₹41 to ₹43 per share |
Goldline Pharmaceutical IPO Latest GMP (Grey Market Premium) Today
Visit us daily to get the latest update on IPO GMP. You will get the latest update of SME IPO GMP.
Goldline Pharmaceutical IPO Lates GMP (grey market premium) available here
- Price Band of Goldline Pharmaceutical IPO is ₹41 to ₹43 per share.
- Current GMP (Grey Market Premium) for Goldline Pharmaceutical IPO is:
- It is a premium for the IPO cut-off price .
- As per Goldline Pharmaceutical IPO Taday’s GMP Data, the estimated listing price of Goldline Pharmaceutical IPO shares can be:
- Estimated listing price calculated as Goldline Pharmaceutical IPO cutoff price or allotment price: ₹43 per share + IPO current GMP: .
Goldline Pharmaceutical SME IPO GMP |
||
| Date | GMP (₹) | Listing Price (₹-Estimated) |
| Today | 15.75 | |
| 13 May 2026 | 15.75 | |
| 12 May 2026 | 15 | |
| 11 May 2026 | 15 | |
| 10 May 2026 | 16 | |
| 9 May 2026 | 11 | |
| 8 May 2026 | 8 | |
Total shares offered by Goldline Pharmaceutical IPO is 27,00,000 shares (aggregating up to 11 crore 61 lakh rupees). Out of which 9,00,000 shares (33.33%) is reserved for retail, 3,90,000 shares (14.44%) is reserved for HNI (NII), 12,72,000 shares (47.11%) is reserved for QIB, and 1,38,000 shares (5.11%) is reserved for market maker Nirman Share Brokers Pvt Ltd.
Goldline Pharmaceutical IPO will open for subscription on 12 May 2026 and close on 14 May 2026. Basis of allotment will be decided on 15 May 2026, initiation of refund will begin on 18 May 2026 and finally IPO will be listed on 19 May 2026 at BSE SME. Cumulative Capital Pvt Ltd is the book running lead manager and Bigshare Services Pvt Ltd is the registrar of the Goldline Pharmaceutical IPO.
Goldline Pharmaceutical IPO Price Band and Market Lot
Goldline Pharmaceutical has set a price band of ₹41 to ₹43 per share and lot size is of 3000. Retail investors can bid for a minimum and maximum of 2 lots (6,000 shares), requiring an investment of ₹2,58,000, sHNI investors can bid for a minimum of 3 lots (9,000 shares), requiring an investment of ₹3,87,000 and bHNI investors can bid for a minimum of 8 Lots (24,000 shares), requiring an investment of ₹10,32,000 calculated at the cut-off price ₹43 per share (the upper end of the price band).
| Goldline Pharmaceutical IPO Price | |
| Face Value | ₹10 per share |
| Price Band | ₹41 to ₹43 per share |
| Lot Size | 3,000 shares |
| IPO Issue Type | Book Built Issue |
About Goldline Pharmaceutical
Goldline Pharmaceutical IPO GMP FAQs
The latest Grey Market Premium (GMP) of Goldline Pharmaceutical IPO is .
It is a premium to the IPO cut-off price Goldline Pharmaceutical. GMP gives a rough estimate of the premium at which the stock might list. It’s not guaranteed but often aligns with market sentiment.
As per latest GMP data, the expected return for Goldline Pharmaceutical IPO can be .
Expected listing listing price for Goldline Pharmaceutical share can be .
According to latest GMP data pattern expected listing price and profit per share for Goldline Pharmaceutical IPO can be . Expected listing price is calculated by adding the GMP to the IPO issue price. Estimated listing price = IPO issue price + current GMP. This value changes as the GMP fluctuates.
GMP is an unofficial indicator and can be manipulated. It should never be the sole reason to apply. Always consider fundamentals and risk tolerance. Subscription demand, financial performance, market sentiment, peer valuation, and overall liquidity can impact the GMP trend.
Disclaimer:
- Grey market premium (GMP) indicates investors are willing to pay more than the issue price.
- A negative GMP suggests that the IPO’s share is likely to be listed on the stock exchange at a discount, and a positive Grey Market Premium suggests that the IPO’s share is likely to be listed on the stock exchange at a profit.
- Do not subscribe for IPO by just seeing the premium Price, It can change anytime
- We do not trade/deal or buy/sell IPO forms in the grey market and GMP prices shown here are gathered from various sources.